Rheumatology
Conference Coverage
Biomarkers for measuring lupus nephritis treatment response gain ground
A panel of protein biomarkers in urine could achieve better identification of lupus nephritis patients who are likely to respond to treatment.
Conference Coverage
MACE, VTE rates compared between TNF and JAK inhibitors for AxSpA and PsA
Patients with axial spondyloarthritis and psoriatic arthritis who used JAK inhibitors did not have higher risk of myocardial infarction or stroke...
From the Journals
Investigational drug peresolimab shows efficacy in patients with RA
Only patients taking peresolimab 700 mg had a significantly greater change in Disease Activity Score in 28 Joints based on the C-reactive protein...
From the Journals
Rheumatoid arthritis linked to increased Parkinson’s risk
“If patients with rheumatoid arthritis begin exhibiting motor symptoms such as muscle rigidity, tremors, or slowed movement, it is imperative that...
From the Journals
Cutaneous vasculitis curtails quality of life
Survey respondents described a generally poor health-related quality of life that was detailed as more severe with a skin-specific instrument than...
From the Journals
Colchicine’s 2010 price spike had major impact on gout care
Colchicine prescriptions dropped sharply and patient visits for gout-related symptoms increased significantly after a 2010 U.S. Food and Drug...
Conference Coverage
Care for patients with gout needs improvement, says doctor
Failure to understand the gout disease process and goals of urate-lowering therapy (ULT) is a key barrier to achieving optimal gout therapy.
Conference Coverage
Normal CRP during RA flares: An ‘underappreciated, persistent phenotype’
In about 5% of patients with seropositive RA, C-reactive protein levels were normal despite disease flares during a 5-year period. The findings...
News from the FDA/CDC
FDA fast tracks potential CAR T-cell therapy for lupus
The cellular therapy depletes CD19-positive B cells with the goal of ‘‘resetting’’ the immune system to achieve durable remission.
Conference Coverage
Long-COVID rate may be higher with rheumatic diseases
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients...
Conference Coverage
Can you spot hypermobility spectrum disorder?
“I think a lot of these patients were diagnosed with fibromyalgia,” Dr. Carroll said. “It’s incumbent upon us to be able to start teasing some of...